• Title/Summary/Keyword: 약물상호작용

Search Result 206, Processing Time 0.025 seconds

Current Guidelines for Non-Steroidal Anti-Inflammatory Drugs (비스테로이드 소염제의 최신 사용 지침)

  • Park, Min-Gyue;Yoo, Jae-Doo;Lee, Kyu-Ho
    • Journal of the Korean Orthopaedic Association
    • /
    • v.55 no.1
    • /
    • pp.9-28
    • /
    • 2020
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used drugs worldwide for chronic pain, such as arthritis, and there are many different types depending on their composition and mechanism. After long-term use, various side effects can occur, such as gastrointestinal and cardiovascular complications. With a similar analgesic effect to that of traditional non-selective NSAIDs, cyclooxygenase-2-selective NSAIDs have been highly anticipated, because they could complement gastrointestinal tolerance. On the other hand, because of concerns about cardiovascular safety in 2004 and 2005, and the license withdrawals of rofecoxib and valdecoxib, the interest in the side effects of NSAIDs is increasing. Therefore, it is important to use the necessary drugs at a minimum, considering the side effects and interactions of each drug. This study examined the side effects and characteristics of each NSAID that may occur and reviewed the recent research and guidelines related to the use of non-selective NSAIDs and cyclooxygenase-2-selective NSAIDs.

Effect of Diazepam on the Oxytocin Induced Contraction of the Isolated Rat Uterus (Oxytocin의 자궁수축작용에 미치는 Diazepam의 영향)

  • Park, Yoon-Kee;Lee, Sung-Ho;Kwon, Oh-Cheol;Ha, Jeoung-Hee;Lee, Kwang-Youn;Kim, Won-Joon
    • Journal of Yeungnam Medical Science
    • /
    • v.9 no.2
    • /
    • pp.359-381
    • /
    • 1992
  • This study was designed to investigate the effect of diazepam on the spontaneous contraction and oxytocin induced contraction of the isolated rat uterus. Female rat(Sprague-Dawley) pretreated with oophorectomy and 4 days administration of estrogen, weighing about 200 g, was sacrificed by cervical dislocation, and the uteruses were isolated. A longitudinal muscle strip was placed in temperature controlled($37^{\circ}C$) muscle chamber containing Locke's solution and myographied isometrically. Diazepam inhibited the spontaneous contraction and oxytocin induced contraction of the isolated rat uterus in a concentration-dependent manner. GABA, muscimol, a GABA A receptor agonist, bicuculline, a competitive GAGA A receptor antagonist, picrotoxin, a non competitive GABA A receptor antagonist, baclofen, a GABA B receptor agonist, and delta-aminovaleric acid, a GABA B receptor antagonist, did not affect on the spontaneous and oxytocin induced contraction of the isolated rat uterus. The inhibitory actions of diazepam on the spontaneous and oxytocin induced contraction were not affected by all the GABA receptor agonists and antagonists, but exceptionally potentiated by bicuculline. This potentiation-effect by bicuculline was not antagonized by muscimol. In normal calcium PSS, addition of calcium restored the spontaneous contraction preinhibited by diazepam and recovered the contractile of oxytocin preinhibited by diazepam. A23187, a calcium inophore, enhanced the restoration of both the spontaneous and oxytocin induced contraction by addition of calcium. In calcium-free PSS, diazepam suppressed the restoration of spontaneous motility by addition of calcium but allowed the recovery of spontaneous motility to a considerable extent. Diazepam could not inhibit some development of contractility by oxytocin in calcium-free PSS, but inhibited the increase in contractility by subsequent addition of calcium. These results suggest that the inhibitory action of diazepam on the rat uterine motility does not depend on or related to GABA receptors and that diazepam inhibits the extracellular calcium influx to suppress the spontaneous and oxytocin induced contractilities.

  • PDF

Studies on the Drug Interaction of Silymarin with Promethazine Hydrochloride in Thioacetamide Hepatotoxicity of Rats (흰쥐의 Thioacetamide에 의한 간장해에 미치는 Silymarin 과 염산 Promethazine의 약물 상호작용에 관한 연구)

  • 조윤희
    • YAKHAK HOEJI
    • /
    • v.23 no.1
    • /
    • pp.41-49
    • /
    • 1979
  • By intraperitoneal administration of thioacetamide to rats, acute liver injury was produced. In these rats, the level of serum GOT and GPT activities showed a remarkable increase and the principal histopathologic change was centrilobular hepatic necrosis. In this study, combined administration of silymarin with promethazine hydrochloride to the rats with acute liver injury which was produced by thioacetamide inhibited the increase of serum transaminase activities and protected the histopathologic change, showing comparatively more improved results than simple administration of silymarin alone. On the basis of these results, it is suggested that promethazine hydrochloride potentiates the effectiveness of silymarin in acute thioacetamide hepatotoxicity of rats.

  • PDF

Drug Interaction of Nalidixic Acid and Probenecid in Rabbits (Nalidixic Acid와 Probenecid의 약물 상호 작용)

  • 최준식
    • YAKHAK HOEJI
    • /
    • v.27 no.2
    • /
    • pp.133-138
    • /
    • 1983
  • The interaction between nalidixic acid and probenecid was studied pharmacokinetically in rabbits. The blood level and the area under the concentration curve(AUC) of nalidixic acid administered orally in dose of 100mg/kg was elevated by the coadministration of probenecid. Probenecid inhibited both the urinary excretion and the biliary excretion of nalidixic acid. Therefore, biological half-life of nalidixic acid was prolonged by the coadministrarion of probenecid. It was considered that the coadmini-stration of probenecid is more desirable than the single administration of nalidixic acid for the therapeutic effect.

  • PDF

Drug-Biomacromolecule Interaction (VI) Binding of Nalidixic Acid and Probenecid to Bovine Serum Albumin (약물과 생체고분자간의 상호작용(VI) Nalidixic Acid 및 Probenecid와 우혈청 단백간의 결합에 관한 연구)

  • 김종국;임연수;양지선
    • YAKHAK HOEJI
    • /
    • v.27 no.4
    • /
    • pp.257-261
    • /
    • 1983
  • Binding of nalidixic acid which is used primarily in the treatment of urinary infection and probenecid which is used as a uricosuric agent to bovine serum albumin were studied using difference spectrophotomeric method. 2-(4'-Hydroxybenzeneazo) bcnzoic acid as a spectrophotometric probe was used for measuring the binding of nalidixic acid and probenecid to bovine serum albumin. The association constants of nalidixic acid and probenecid were $1.58{\times}10^{4}M^{-1}$ and $1.70{\times}10^{4}M^{-1}$, respectively.

  • PDF

Drug Interaction between Ginseng Extract (GE) and Sorafenib (쏘라페닙과 홍삼추출물간의 약물상호작용)

  • Lee, Nam-Hee;Park, Ho-Jae;Rho, Ja-Sung;Kim, Mi-Kyung;Lee, Yu-Kyoung;Cho, Eun-A;Heo, Jeong;Cho, Mong;Hwang, Tae-Ho
    • Journal of Life Science
    • /
    • v.21 no.11
    • /
    • pp.1518-1525
    • /
    • 2011
  • Sorafenib is the only approved systemic, therapeutic agent for hepatocellular carcinoma (HCC). The use of Ginseng Extract (GE) in cancer patients is growing worldwide; however, drug interaction between sorafenib and GE has not been illuminated. Four different human cancer cell lines including HepG2 were used and immunocompetent mice were implanted subcutaneously with a mouse HCC cell line. Treatment with low dose GE stimulated cell growth, while a high dose inhibited growth. pERK (phosphorylation of extracellular signal-regulated kinase) was concomitantly increased and decreased respective of different doses of GE. Antitumoral effect of sorafenib decreased in non-proliferating phase cells but was sensitized after low dose GE (LDG) treatment. PD98059 (ERK phosphorylation inhibitor) efficiently blocked ERK phosphorylation, resulting in loss of sorafenib sensitization even after LDG treatment. In the HCC mouse model, LDG alone slightly increased tumor size while sorafenib alone significantly decreased it. However, a combination of LDG and sorafenib significantly decreased tumor size compared with sorafenib alone. Increase of pERK was observed in some normal mice organs and mild inflammatory change was observed in some of these organs, suggesting pERK activation by LDG may cause unexpected toxicity in normal cells. GE, dose-dependently, induced stimulation or inhibition in some human cancer cell lines. Combinational use of GE and sorafenib possibly potentiated an antitumoral response to sorafenib. pERK level has been provided as a potential predictive marker for sorafenib. Our result may suggest GE's dual effects in relation to pERK level in HCC cancer cell lines, and that certain doses of GE can sensitize sorafenib.

Discussion on the Introduction of Geriatric Specialized Pharmacists in Regional Pharmacy (지역 약국의 노인 전문 약사 도입 논의)

  • Jeong, Su-Cheol
    • The Journal of the Korea Contents Association
    • /
    • v.19 no.8
    • /
    • pp.303-315
    • /
    • 2019
  • In 2018, 14.3 percent of South Korea's elderly population aged 65 or older entered an aged society and is expected to enter a super-aged society with more than 20 percent of the elderly population around 2025. Older adults often visit different medical institutions to take medicine, which requires medication management, such as interaction between each drug. In this study, we wanted to analyze the U.S. system, which specializes in drug management for the elderly, and Korea's system, which is about to enter a super-aged society, to find a systematic way to manage drugs for the elderly. The method of study was a systematic literature study on elderly drug management in Korea and the United States. Studies have shown that the United States has enacted the Medication Therapy Management (MTM) for the elderly and has been running the Senior Drug Enforcement Program. In Korea, a community care business is underway to manage drugs for senior citizens, but it is analyzed that the elderly need to have a special medicine system for senior citizens to use them more safely.

Dosage Adjustment before and after Warfarin - Rifampin Combination Therapy (와파린-리팜핀 병용 시 용량 조절)

  • Kim, Dong-Hyun;Kim, Kyung-Hwan;Choi, Kyung-Hee;Lee, Kwang-Ja;Lee, Hye-Suk;Son, In-Ja;Kim, Ki-Bong;Lee, Jae-Woong;Ahn, Hyuk
    • Journal of Chest Surgery
    • /
    • v.41 no.3
    • /
    • pp.354-359
    • /
    • 2008
  • Background: Warfarin is used as an anticoagulant and it is mainly excreted by the liver metabolism (the R-form is mainly metabolized by cytochrome p450 3A4, and the S form by cytochrome p450 2C9). Rifampin is usually used for tuberculosis or endocarditis, and it is a representative drug that induces the CYP families, including 3A4 and 2C9. The anticoagulation effect of warfarin decreases through the increased metabolism that's due to the induction of enzymes, and this iscaused by rifampin when patients take these two medicines together. No one has suggested appropriate guidelines regarding this drug interaction even though an appropriate adjustment of warfarin's dosage is needed. We examined the drug interaction in patients who received warfarin-rifampin combination therapy according to the time interval, and the factors affecting drug interaction were analyzed. Based on the data, we tried to determine the clinically available warfarin dosage guidelines before and after taking this drug combination. Material and Method: We reviewed the OO University Hospital anticoagulation service team's follow up sheets that were filled out from Jan '1998 to Sep 2006 for the patient who took warfarin - rifampin combination therapy (n=15). Result: The average INR of all the patient before rifampin administration was $2.25{\pm}0.52$ $(mean{\pm}SD)$, and that value for the first 100 days after rifampin administration was $1.98{\pm}0.28$. The p value for these two sets of data showed no correlation (paired t-test, p>0.05). The average INR of all the patient before rifampin cessation was $2.19{\pm}0.34$, and the value after rifampin cessation was $2.49{\pm}0.43$. The p value of these two showed correlation (paired t-test, p<0.05) but the average INR falls between the therapeutic INR range. Conclusion: The warfarin dose adjustment equation of before and after warfarin-rifampin combination therapy was derived based on this study's results because the warfarin dosage adjustment of the anticoagulation service team was considered appropriate.

Toxicological Studies of Antioxidants, Butylated Hydroxytoluene(BHT) and Butylated Hydroxyanisole(BHA) (항산화제 BHT와 BHA의 안전성)

  • Choe, S.Y.;Yang, K.H.
    • Korean Journal of Food Science and Technology
    • /
    • v.14 no.3
    • /
    • pp.283-288
    • /
    • 1982
  • 식품에 항 산화제로 첨가시키는 BHT와 BHA의 독성에 대해 고찰하였다. BHT와 BHA는 실험동물에서 간, 폐, 신장, 순환계, 생식계, 등에 여러 영향을 주며 이러한 영향은 동물의 종류와 성에 따라 상당한 차이를 나타내고 있다. 대부분 실험에 사용된 BHT와 BHA의 양이 인체가 매일 식품으로부터 흡수할 수 있는 양보다는 훨씬 많은 양을 사용하였기 때문에 동물실험의 결과로 인체에 유독성을 직접 판단하기는 어렵고 이들의 안전성에 대해서는 보다 체계적인 연구가 앞으로 요구된다. 미량의 BHT와 BHA를 장기간 복용하였을 때 생기는 부작용에 대한 연구가 필요하며 또한 이들 항 산화제는 약물대사에 관여하는 효소의 합성내지 활성도를 증가시키는 것으로 알려져 있기 때문에 체내에서 다른 약물의 대사 및 독성에 어떤 상호 작용을 가져오는 지에 대한 면밀한 연구가 요구되고 있다. 더불어 본 논문은 현시점에서 이들 항산화제의 식품에 첨가여부를 논쟁하고자 하는 의도가 전혀 없음을 명백히 하는 바이다.

  • PDF